SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-23-000642
Filing Date
2023-03-06
Accepted
2023-03-06 10:43:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13D sc13da107609011_03062023.htm SC 13D/A 147352
2 EXHIBIT 99.1 - COOPERATION AGREEMENT, DATED MARCH 1, 2023 ex991to13da107609011_030623.pdf SC 13D/A 4475795
  Complete submission text file 0000921895-23-000642.txt   6238851
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Subject) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45969 | Film No.: 23707920
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 119 ROWAYTON AVENUE 2ND FLOOR NORWALK CT 06853
Business Address 119 ROWAYTON AVENUE 2ND FLOOR NORWALK CT 06853 212-230-3220
DIALECTIC CAPITAL MANAGEMENT, LP (Filed by) CIK: 0001411512 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A